Andrew Roddam | Chief Strategy Officer
Everyone medicines

Dr Andrew Roddam is a life sciences executive and epidemiologist with over 25 years’ experience spanning academia, global pharmaceuticals, biotechnology, and large-scale public health initiatives. His career has focused on the use of data, real-world evidence, and health system design to improve patient outcomes. Andrew is currently Chief Strategy Officer at EveryONE Medicines, where he is helping to build a scalable framework for the development, regulation, and access of truly individualised genetic medicines. The organisation is pioneering new approaches to deliver bespoke therapies—initially for patients with ultra-rare, often life-limiting CNS diseases—by rethinking how medicines are developed, approved, and made accessible. Previously, Andrew was Chief Executive Officer of Our Future Health, the UK’s largest ever health research programme, delivered in partnership with the NHS. He led the organisation from inception, building a national capability integrating genetic and real-world data at scale. Earlier in his career, Andrew held senior leadership roles at GSK and Amgen. He is Chair of SNOMED International, holds a DPhil in Statistics from the University of Oxford, and has authored over 100 scientific publications. His work is consistently mission-led, focused on translating scientific innovation into real impact for patients.